Health Ministry: No shortage of HCQ tablets in country

New Delhi: The health minitry has ensured that there is no shortage of hydroxychloroquine tablets (HCQ) in the country at present as well as in the future, accordinh to Union Health Ministry Joint Secretary Lav Aggarwal.

“It is ensured that not only today even in future there will not be any lack of HCQ (hydroxychloroquine) as and when needed,” Aggarwal said.

Earlier, Temporary licensed was granted by the India for the export of paracetamol and anti-malarial drug hydroxychloroquine (HCQ) in appropriate quantities to some countries, which have been badly affected by the coronavirus pandemic.

According to the Indian Council of Medical Research (ICMR), “hydroxychloroquine is recommended only to those asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and asymptomatic household contacts of laboratory-confirmed cases.”

“5,194 positive confirmed cases have been reported and 402 people have been discharged so far. Over the last 24 hours, 773 positive cases have been reported. A total of 149 deaths have been reported. As many as 32 people died yesterday,” Agarwal said.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre